The Renal Association  by unknown
Abstracts 255
demonstrated an increase in IgA levels. No explanation can yet
be drawn for these abnormalities.
Lymphokine "skin reactive factor" (SRF) in lymphocyte
culture supernatants from patients with nephrotic syndrome (NS).
G. LaGrue, A. Branellec, S. Xheneumont, G. Hirbec and B. Well.
Department of Nephrology, Hôpital Henri-Mondor, INSERM et
Association Claude Bernard, Creteil, France. In patients with
the nephrotic syndrome (NS), the role of an increased capillary
permeability is suggested by biological data and clinically by the
prompt recurrence of proteinuria in some patients after trans-
plantation. We have investigated the presence of "skin reactive
factor" (SRF) in lymphocyte culture supernatants from these
patients, for SRF is an enhancing vascular permeability factor.
The lymphocyte culture was composed of 106 Iymphocytes/ml
in Medium 199 (80%) plus human normal serum (HNS) AB +
(20%), or in MEM Eagle. The reaction was stimulated with
PHA-M Difco or concanavaline A (5 g/ml). Supernatants were
taken off on the third day; 0.1 ml of supernatant was injected
intradermally to Hartley guinea pigs. Vascular permeability
(immediate reaction) was determined by the Evans Blue tech-
nique; and measurement of the blue areas, after the guinea pig was
killed, was performed 30 mm after injection. Delayed reaction
was studied by the evaluation of the cutaneous inflammatory
process during a 24-hr period (erythema, induration), and by
histological study at 24 hr. Immediate reactions (vascular
permeability). No vascular permeability enhancing activity was
found in control supernatants (medium alone, medium + HNS,
+concanavaline or PHA). In supernatants from 23 normal
subjects, the reactions were positive only in 4 individuals with a
mean area of 50 71 mm2. Supernatants from 46 patients with
NS gave strongly positive results in 40 cases (area> 50 mm2). In
relation to histological types of NS, the results are as follows
(blue area): NS with minimal optical changes, 210 112 mm2;
NS with extramembranous GN, 161 80mm2; NS with
membranoproliferative GN, 174 103 mm2; and control
subjects, 50±71 mm2. Difference is highly significant between
each group and controls). Delayed reactions. For this study,
PHA-stimulated supernatants were not used for they may give
positive results. Supernatants positive with the blue method
always give delayed positive results: erythema from the 2nd to
4th hr; then, induration maximum from the 12th to 15th hr,
which disappeared after 24 hr, with area, 20 to 50 mm2. Histo-
logic findings show mixed type infiltration with morphopoly-
nuclear (some basophiles) and mononuclear cells. Negative
supernatants with blue technique and control supernatants give
negative delayed results. Pharmacological findings. The action of
some inhibitors and activators was studied and compared to
results obtained in guinea pigs for SRF. There was no inhibition
of immediate reaction with antihistamine, antiserotonine,
indometacin or salicylate; meclofenamate and pyridinol carba-
mate inhibited the reaction. Enhancement of the reaction was
observed with diethyldithiocarbamate (DTTC) and with the
addition of HNS to MEM supernatants. Physicochemical
findings. Biological activity disappeared by heating at 100°C,
and was reduced 50% by heating 30 mm at 56°C. It was not
dialyzable, and could be precipitated by 66% ammonium sulfate.
It was destroyed by pepsin and not modified by desoxyribo-
nuclease. By Sephadex G 200 chromatography, activity was
found in the fourth fraction, which in immunoelectrophoresis
migrated with the albumin fraction. In summary, lymphocyte
culture supernatants from patients with the NS contain SRF
with an enhancing vascular permeability and proinflammatory
effect; this factor is not present in normal subjects and in control
supernatants. Pharmacological and biological properties of this
factor are similar to guinea pig SRF. Modifications observed
with meclofenamate, DTTC and addition of NHS suggest that it
could be an activator of the kinin system. Physicochemical
findings show that it is a protein migrating as albumin. To date,
the lymphokines have been studied in animals but seldom in
humans. Our results show that in humans, variations in lympho-
kine production may be present. Pathogenic implications are
now under study.
The Renal Association, London, England, June 20, 1974
Rhythms of urine excretion in renal failure. P Hillier, R. Cove-
Smith and M. S. Knapp. City Hospital, Nottingham. The circa-
dian rhythms of many physiological functions, including urine
excretion have previously been documented in healthy subjects.
Abnormal rhythms have been described in a variety of disorders.
Menzel (1962) reported abnormal rhythms of urine excretion in
patients with renal failure, but his report lacks detail, especially
relating to the clinical condition of the patients studied. Patients
known to have renal failure and to be in a stable clinical state
have been studied. Simultaneously, two healthy control subjects
(matched for sex and age) were studied using the same tech-
niques. Subjects were trained to record data on temperature,
blood pressure, pulse rate and urine volume. Over a period of
days, they made records and also saved aliquots of all urines
passed. These urine specimens were later analyzed. The control
subjects had normal rhythms. Seven of eight patients in renal
failure demonstrated an increased nocturnal and a decreased
daytime excretion of total solute, sodium and water. Potassium
excretion remained maximal in the daytime. Studies in some
patients indicate that the abnormal pattern of excretion may
relate to an abnormal response to the recumbent posture, rather
than to a reversal of an intrinsic circadian rhythm. The magni-
tude of these variations of excretion (greater than 100%) despite
severe renal impairment, and the possible mechanisms involved,
are of interest. The results suggest that large percentage changes
in glomerular filtration rate may occur.
Acute reversible renal failure in patients with acute cholecystitis
and cholangitis. R. P. Burden, J. G. Gray and G. M. Aber. Wessex
Regional Renal Unit, St. Mary's General Hospital, Portsmouth,
and Renal Research Laboratory, North Staffordshfre Medical
Institute, Stoke-on-Treat, England. Acute renal failure is a well-
known complication of several extrahepatic biliary tract dis-
orders including biliary tract surgery in the presence of
obstructive jaundice, but there is little information regarding
acute renal failure in otherwise uncomplicated acute cholecystitis.
Renal function was measured serially in 14 patients with acute
cholecystitis and in 2 with acute cholangitis. Whereas in six
patients there was no evidence of renal impairment, four had
modest elevations of plasma urea and creatinine concentrations
and six had acute renal failure of whom three required peritoneal
dialysis. Renal function returned to normal. There was evidence
of intravascular coagulation in all patients with renal failure.
Only one patient who developed acute renal failure was hypovo-
lemic, another had a positive blood culture and two had pan-
creatitis. It is suggested that the renal changes were a result of
intravascular coagulation, itself secondary to various factors,
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and although emergency biliary tract surgery has been advocated
for acute biliary tract diseases complicated by renal failure, the
return to normal renal function in the present study favorably
indicates conservative management.
The urinary excretion of 1gM, IgG and C3 related materials
FDP and sheep hemagglutinins in proliferative glomerulonephritis
and following renal transplantation. J. L. Anderton, M. S. Hoq,
M. Cunningham, J. M. Borowczyk, J. S. Robson and J. D. Cash.
Western General Hospital. The urinary concentration of material
related to complement (C3) 1gM and IgG was measured
along with fibrin/fibrinogen degradation products (FDP) and
heterophile (sheep) hemagglutinins (SHA) in 15 patients with
proliferative glomerulonephritis and 10 patients after renal
transpianation. There was a significant correlation between both
the FDP and SHA content and the concentrations of 1gM, IgG
and C3 related materials. However, detailed serial studies in
patients with proliferative glomerulonephritis revealed that not
all urine specimens with a high content of 1gM, IgG and C3 re-
lated materials had a high concentration of FDP or SHA, or
both. Investigations on the ten renal transplant patients con-
firmed previous reports that urine FDP and SHA estimations
provided parallel information on the detection of rejection.
Similar patterns in the excretion of 1gM, IgG and C3 related
materials were observed in all patients. The responses to oral
administration of indomethacin were studied in ten patients with
active proliferative glomerulonephritis. In four patients there
was a fall in the urine content of FDP, SHA, 1gM and C3 related
materials during the period of indomethacin administration, and
this was associated with an improvement in renal function. In
the remaining six patients there was no fall in most of the urinary
components, and this was associated with deterioration in renal
function.
Immunity to kidney-derived antigen in human and experimental
renal transplantation. R. J. Williams, Karen Eyres, N. P. Mallick,
W. MeN. Orr, G. Taylor and G. Williams. Renal Transplantation
Unit, Manchester Royal Infirmary and University of Manchester,
Manchester, England. In order to extend our previous studies
using the leucocyte migration test (LMT) of immunity to a
kidney-derived antigen in glomerular disease and renal trans-
plantation, we have developed a model using paired, unrelated
dogs. Five pairs of animals have now been studied. All animals
were unilaterally nephrectomised and, after an interval, one dog
from each pair received a renal allograft from its fellow. The
grafts were placed in the neck and no immunosuppression was
used. The LMT was performed daily on recipient animals both
before and after transplantation. Autologous donor-specific and
homologous leucocytes, kidney, liver and skeletal muscle were
used as sources of DL-A and organ-specific antigens. Inhibition
of migration with donor-specific leucocyte and kidney antigens
was observed prior to clinical evidence of rejection, which was
confirmed histologically. Concurrently, inhibition was also ob-
served with autologous kidney antigen and histological damage
was noted in the recipient's own nontransplanted kidney accom-
panied by increasing proteinuria. Autologous serum withdrawn
daily and added to the test culture medium abolished the inhibi-
tion of migration, suggesting the development of blocking factor.
Preliminary studies in four patients after cadaveric renal trans-
plantation demonstrate that a factor which abolishes inhibition
of the LMT is present during clinical rejection episodes.
Turnover and distribution of platelets in patients with lupus
nephritis. W. F. Clark, M. L. Lewis, J. S. Cameron and V. Parsons.
Department of Medicine, Guy's and King's College Hospital and
Department of Haematology, King's College Hospital, London,
England. The survival of autologous platelets labelled in vitro
with 51Cr was determined by serial blood samples with separation
and counting of the washed platelets. When the disappearance
curve was linear, survival time was determined by simple exten-
sion to zero activity; when it was curvilinear, the initial slope
was extrapolated to zero. Serial external counting for 51Cr radio-
activity was performed over the right kidney and spleen for five
days. Six control subjects and 14 patients with systemic lupus and
renal involvement were studied. In the control subjects platelet
survival was 9.4± 0.5 (sEM).2 days. In eight patients with lupus
and diffuse proliferative glomerulonephritis, the mean survival
was 6.4± 1.1 days, and in one patient with lupus membranous
nephritis, 7.5 days. In four patients with minor focal or no
glomerular abnormalities, survival was 8.4 0.4 days; and in a
single patient who had been treated with dipyridamole and
aspirin, with acute active lupus and diffuse proliferative nephri-
tis, survival was 9.4 days. To assess renal uptake of platelets, the
ratio right kidney/spleen at 50% survival over right kidney!
spleen at 0 to 24 hr was calculated. This ratio averaged 0.50±
0.17 in the control subjects and was only 0,04 in a patient with
idiopathic thrombocytopenic purpura. In the patients with lupus
and diffuse proliferative glomerulonephritis, the ratio was
1.04±0.25; in the patient with membranous nephritis, 2.50;
and in three patients with minimal focal lesions, 0.85 0.25. The
results confirm that in patients with lupus nephritis, platelet
survival is shorter than normal. This reduction in platelet sur-
vival is thought not to be a consequence of circulating anti-
platelet antibody. The evidence suggests that platelets may be
involved in soluble complex deposition in the kidney in human
systemic lupus erythematosus nephritis. Alternatively, the kidney
uptake of platelets could represent prominent platelet involve-
ment in localized intrarenal coagulation or both.
Adaptations in metabolic acidosis: A reinterpretation. Edmund
Bourke and Jane Oliver. Department of Medicine, Trinity College,
Dublin, Ireland. The concept that increased ammonia secretion
in acidosis results in increased H excretion derives from the
practice of writing the formula of glutamine in the unionized
form. At physiological pH glutamine is ionized, gives rise to
NH (not NH3) and does not result in elimination of H An
alternative interpretation is needed. Following oral administra-
tion of HC1 to rats on a constant nitrogen intake, the enhanced
ammonium excretion is coupled with an equimolar decrease in
urea production falling by 32% of control values. NH4HCO3
administration did not alter urinary ammonium but was re-
covered as urea. By contrast, following NH4CI administration,
only 15% of the increased nitrogen load was recovered as urea,
the remainder being accounted for as urinary ammonium. Argu-
ments will be presented to support the following interpretation:
Amino nitrogen is ordinarily converted to urea. Each turn of the
urea cycle utilizes two bicarbonate ions. The subsequent meta-
bolism of the remaining carbon skeleton generates bicarbonate.
In HCI acidosis waste nitrogen bypasses urea synthesis to be
excreted as NH. No bicarbonate is utilized, but the carbon
skeleton still generates bicarbonate. The HCO3 produced from
conversion of NH4HCO3 to urea is balanced. Urea formation
from NH4C1 utilizes net HCO. The consequent acidosis causes
a shift in disposal of waste nitrogen of amino acids from urea to
urinary NH with generation of new NCO. Thus, total urea
excretion is much less following NH4CI than NH4HCO3, Inhibi-
tion of glutamine synthetase with methionine sulphoxamine
decreased ammonium excretion in acidosis but did not effect the
reduced urea production. This suggests a primary role for the
urea cycle in adaptations to metabolic acidosis.
1-Alpha-hydroxycholecalciferol: A treatment for azotemic
osteodystrophy. G. R. D. Catto, M. MacLeod, B. Pelc and E.
Kodicek. Department of Medicine, University of Aberdeen
Scotland. It has been known for more than a century that patients
with renal failure develop metabolic bone disease. The im-
portance of this association has been appreciated only since
recent advances in treatment have extended life expectancy and
demonstrated that bone disease is an important factor in limiting
the full rehabilitation of many patients. Investigation and
management of the problem have been hindered until recently
by the absence of a sensitive method for detecting in vivo small
changes in the mineral content of bone. The most careful radio-
logical assessment may not detect skeletal demineralization
until as much as 3O% of skeletal calcium has been lost. During
the last 18 months, 19 patients receiving maintenance hemo-
dialysis have been assessed for evidence of metabolic bone
disease clinically, radiologically, histologically and by photon
absorption and neutron activation techniques. Osteomalacia was
the predominant abnormality noted on the bone biopsy samples.
The rate of progression of the demineralizing condition has been
accurately quantitated. Three patients with established, progres-
sive metabolic bone disease have been treated with 1-alpha
hydroxycholecalciferol, a synthetic analogue of the vitamin D
derivative 1 ,25-dihydroxycholecalciferol, in an oral dose of
2 g/day. In all three patients, absorption of calcium from the
gastrointestinal tract and skeletal calcium content as measured
by neutron activation analysis were increased.
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Factors influencing the growth of children with chronic renal
insufficiency. P. R. Betts, P. Howse and B. T. Rudd (Introduced by
R. H. R. White). Children's Hospital, Birmingham, England.
Growth retardation is a frequent finding in children with chronic
renal insufficiency. Studies of the growth patterns of 33 such
children have shown that the development of impaired renal
function in infancy has a more deleterious effect upon linear
growth than its onset in later years. A reduction in the growth
velocity of these children occurred once the glomerular filtration
rate fell below 25 ml/min/1.73 m2 or their energy intake was
below 8O% of that recommended for age (Betts & Magrath,
1974). It has been demonstrated that "catch-up" growth does
not necessarily occur following renal transplantation. Studies
have shown that the growth potential of the 33 children, as ex-
pressed by their height for bone age, diminished as chronological
age increased. This may have implications for the optimal age
for transplantation in children. It has previously been suggested
that elevated circulating corticosteroids, which have been found
in uremic adults, may be partially responsible for growth retarda-
tion in children. However, these results were determined using a
fluorimetric technique. We have studied the serum cortisol con-
centrations by the more selective technique of competitive pro-
tein binding and found no evidence of elevated serum cortisol
concentrations in these children.
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